Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00731302 · ClinicalTrials.gov registry record · Phase 1
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT00731302: Completed Phase 1 study, sponsored by Vanderbilt University.
NCT00731302 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 70 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00731302, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study examine whether patients with lupus respond to aspirin , and if not, if that is related to inflammation. We examine the ability of aspirin to inhibit the production of thromboxane in patients with lupus and controls and see if aspirin insensitive thromboxane production is inhibited by meloxicam.
Primary Outcome
a hormone of the prostacyclin type released from blood platelets. It induces platelet aggregation and arterial constriction.
Interventions
- DRUG aspirin and meloxicam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2005-04 |
| Est. Completion | 2017-04 |
| Phase | Phase 1 |
What the finished NCT00731302 record still lists
NCT00731302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 1 intervention - of which aspirin and meloxicam is the first listed.
NCT00731302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00731302 about?
NCT00731302 is a clinical study titled "Aspirin Resistance in Systemic Lupus Erythematosus (SLE)". This study examine whether patients with lupus respond to aspirin , and if not, if that is related to inflammation. We examine the ability of aspirin to inhibit the production of thromboxane in patients with lupus and controls and see if aspirin insensitive thromboxane production is inhibited by mel...
What is the current status of trial NCT00731302?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2005-04. Estimated completion is 2017-04.
What interventions are being tested in trial NCT00731302?
The interventions under investigation include: aspirin and meloxicam (DRUG).
Who is sponsoring clinical trial NCT00731302?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00731302's enrollment target sits among peer trials
70 749th of 2000 higher than 1,227 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia